News

In laboratory experiments, 80 to 100 per cent of the treated plants survived an infection with a high viral load, as the team reports in 'Nucleic Acids Research'. Their paper has been selected as ...
In laboratory experiments, 80 to 100 per cent of the treated plants survived an infection with a high viral load, as the team reports in Nucleic Acids Research. Their paper has been selected as a ...
In laboratory experiments, 80 to 100 per cent of the treated plants survived an infection with a high viral load, as the team reports in "Nucleic Acids Research". Their paper has been selected as a ...
Hyderabad: The Nizam’s Institute of Medical Sciences (NIMS), in the city will soon become the second hospital in the ...
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
dsRNAs designed from functionally characterized siRNAs highly effective against Cucumber mosaic virus, Nucleic Acids Research (2025). DOI: 10.1093/nar/gkaf136 ...
Michael Frank, CEO of Revive, commented: “We look forward to collaborating with a top U.S. cancer istitute to investigate Bucillamine’s potential for solid tumors, confirming its anti-inflammatory and ...
PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...
The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens ...
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...